Magnesium metabolism in hypertension and type 2 diabetes mellitus

American Journal of Therapeutics

Volumn 14, Issue 4, 2007, Pages 375-385

  Barbagallo, Mario ^a   Dominguez, Ligia J ^a   Resnick, Lawrence M ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Diabetes; Glucose intolerance; Hypertension; Insulin resistance; Ionized magnesium; Magnesium

Indexed keywords

MAGNESIUM;

BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; ENVIRONMENTAL FACTOR; ESSENTIAL HYPERTENSION; GLUCOSE TOLERANCE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAGNESIUM BLOOD LEVEL; MAGNESIUM DEFICIENCY; MAGNESIUM METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW; STEADY STATE; VITAMIN SUPPLEMENTATION;

CALCIUM; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MAGNESIUM; MAGNESIUM DEFICIENCY; MAGNETIC RESONANCE SPECTROSCOPY; PRE-ECLAMPSIA; PREGNANCY; SODIUM CHLORIDE, DIETARY; SYNDROME;

EID: 34547679607     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mjt.0000209676.91582.46     Document Type: Review

References (57)

1. Blackfan K, Hamilton B. Uremia in acute glomerular nephritis: the cause and treatment in children. Med Surg J. 1925;193:617-628.
2. Albert DG, Morita Y, Iseri LT. Serum magnesium and plasma sodium levels in essential vascular hypertension. Circulation. 1958;17:761-764.
3. Resnick LM, Laragh JH, Sealey JE, et al. Divalent cations in essential hypertension. Relations between serum ionized calcium, magnesium, and plasma renin activity. N Engl J Med. 1983;309:888-891.
4. Gupta RK, Benovic JL, Rose ZB. The determination of the free magnesium level in the human red blood cell by 31P NMR. J Biol Chem. 1978;253:6172-6176.
5. Gupta RK, Gupta P, Moore RD. NMR studies of intracellular metal ions in intact cells and tissues. Annu Rev Biophys Bioeng. 1984;13:221-246.
6. Resnick LM, Barbagallo M, Bardicef M, et al. Cellular-free magnesium depletion in brain and muscle of normal and preeclamptic pregnancy: a nuclear magnetic resonance spectroscopic study. Hypertension. 2004;44:322-326.
7. Resnick LM, Gupta RK, Laragh JH. Intracellular free magnesium in erythrocytes of essential hypertension: relation to blood pressure and serum divalent cations. Proc Natl Acad Sci USA. 1984;81:6511-6515.
8. Resnick LM, Gupta RK, Bhargava KK, et al. Cellular ions in hypertension, diabetes, and obesity. A nuclear magnetic resonance spectroscopic study. Hypertension. 1991;17:951-957.
9. Resnick LM, Gupta RK, Gruenspan H, et al. Hypertension and peripheral insulin resistance. Possible mediating role of intracellular free magnesium. Am J Hypertens. 1990;3:373-379.
10. Altura BM, Altura BT, Carella A. Magnesium deficiency-induced spasms of umbilical vessels: relation to preeclampsia, hypertension, growth retardation. Science. 1983;221:376-378.
11. Altura BM, Altura BT. Magnesium ions and contraction of vascular smooth muscles: relationship to some vascular diseases. Fed Proc. 1981;40:2672-2679.
12. Altura BM, Altura BT, Gebrewold A, et al. Magnesium deficiency and hypertension: correlation between magnesium-deficient diets and microcirculatory changes in situ. Science. 1984;223:1315-1317.
13. Nadler JL, Buchanan T, Natarajan R, et al. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension. 1993;21:1024-1029.
14. Joffres MR, Reed DM, Yano K. Relationship of magnesium intake and other dietary factors to blood pressure: the Honolulu heart study. Am J Clin Nutr. 1987;45:469-475.
15. Resnick LM, Gupta RK, Sosa RE, et al. Effects of altered dietary calcium intake in experimental hypertension: role of intracellular free magnesium. J Hypertens Suppl. 1986;4:S182-S185.
16. Barbagallo M, Resnick LM, Sosa RE, et al. Renal divalent cation excretion in secondary hypertension. Clin Sci (London). 1992;83:561-565.
17. Resnick LM, Gupta RK, DiFabio B, et al. Intracellular ionic consequences of dietary salt loading in essential hypertension. Relation to blood pressure and effects of calcium channel blockade. J Clin Invest. 1994;94:1269-1276.
18. Sibai BM. Diagnosis, prevention, and management of eclampsia. Obstet Gynecol. 2005;105:402-410.
19. Barbagallo M, Gupta RK, Dominguez LJ, et al. Cellular ionic alterations with age: relation to hypertension and diabetes. J Am Geriatr Soc. 2000;48:1111-1116.
20. Barbagallo M, Resnick LM. Calcium and magnesium in the regulation of smooth muscle function and blood pressure: the ionic hypothesis of cardiovascular and metabolic diseases and vascular aging. In: Sowers JR, ed. Endocrinology of the Vasculature. 1st ed. NJ: Humana Press Inc.; 1996:283-300.
21. Kao WH, Folsom AR, Nieto FJ, et al. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch Intern Med. 1999;159:2151-2159.
22. Sjogren A, Floren CH, Nilsson A. Magnesium, potassium and zinc deficiency in subjects with type II diabetes mellitus. Acta Med Scand. 1988;224:461-466.
23. Resnick LM, Altura BT, Gupta RK, et al. Intracellular and extracellular magnesium depletion in type 2 (noninsulin-dependent) diabetes mellitus. Diabetologia. 1993;36:767-770.
24. Resnick LM. Hypertension and abnormal glucose homeostasis. Possible role of divalent ion metabolism. Am J Med. 1989;87:17S-22S.
25. Resnick LM, Bardicef O, Barbagallo M, et al. 31PNMR spectroscopic studies of oral glucose loading and in situ skeletal muscle ion content in essential hypertension. Hypertension. 1995;26:552.
26. Barbagallo M, Dominguez LJ, Tagliamonte MR, et al. Effects of glutathione on red blood cell intracellular magnesium: relation to glucose metabolism. Hypertension. 1999;34:76-82.
27. Paolisso G, Barbagallo M. Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium. Am J Hypertens. 1997;10:346-355.
28. Resnick LM. Cellular ions in hypertension, insulin resistance, obesity, and diabetes: a unifying theme. J Am Soc Nephrol. 1992;3:S78-S85.
29. McNair P, Christensen MS, Christiansen C, et al. Renal hypomagnesaemia in human diabetes mellitus: its relation to glucose homeostasis. Eur J Clin Invest. 1982;12:81-85.
30. Djurhuus MS. New data on the mechanisms of hypermagnesuria in type I diabetes mellitus. Magnes Res. 2001;14:217-223.
31. Barbagallo M, Dominguez LJ, Galioto A, et al. Role of magnesium in insulin action, diabetes and cardiometabolic syndrome X. Mol Aspects Med. 2003;24:39-52.
32. Takaya J, Higashino H, Kobayashi Y. Intracellular magnesium and insulin resistance. Magnes Res. 2004;17:126-136.
33. Matsunobu S, Terashima Y, Senshu T, et al. Insulin secretion and glucose uptake in hypomagnesemic sheep fed a low magnesium, high potassium diet. J Nutr Biochem. 1990;1:167-171.
34. Lopez-Ridaura R, Willett WC, Rimm EB, et al. Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care. 2004;27:134-140.
35. Barbagallo M, Gupta RK, Resnick LM. Cellular ions in NIDDM: relation of calcium to hyperglycemia and cardiac mass. Diabetes Care. 1996;19:1393-1398.
36. Resnick LM, Militianu D, Cunnings AJ, et al. Pulse waveform analysis of arterial compliance: relation to other techniques, age, and metabolic variables. Am J Hypertens. 2000;13:1243-1249.
37. Resnick LM, Barbagallo M, Gupta RK, et al. Ionic basis of hypertension in diabetes mellitus. Role of hyperglycemia. Am J Hypertens. 1993;6:413-417.
38. Barbagallo M, Shan J, Pang PK, et al. Glucose-induced alterations of cytosolic free calcium in cultured rat tail artery vascular smooth muscle cells. J Clin Invest. 1995;95:763-767.
39. Barbagallo M, Dominguez LJ, Bardicef O, et al. Altered cellular magnesium responsiveness to hyperglycemia in hypertensive subjects. Hypertension. 2001;38:612-615.
40. Barbagallo M, Gupta RK, Resnick LM. Independent effects of hyperinsulinemia and hyperglycemia on intracellular sodium in normal human red cells. Am J Hypertens. 1993;6:264-267.
41. Barbagallo M, Gupta RK, Resnick LM. Cellular ionic effects of insulin in normal human erythrocytes: a nuclear magnetic resonance study. Diabetologia. 1993;36:146-149.
42. Barbagallo M, Gupta RK, Bardicef O, et al. Altered ionic effects of insulin in hypertension: role of basal ion levels in determining cellular responsiveness. J Clin Endocrinol Metab. 1997;82:1761-1765.
43. Dominguez LJ, Barbagallo M, Sowers JR, et al. Magnesium responsiveness to insulin and insulin-like growth factor I in erythrocytes from normotensive and hypertensive subjects. J Clin Endocrinol Metab. 1998;83:4402-4407.
44. Resnick LM. Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders. Am J Med. 1992;93:11S-20S.
45. Resnick LM. Ionic basis of hypertension, insulin resistance, vascular disease, and related disorders. The mechanism of "syndrome X". Am J Hypertens. 1993;6:123S-134S.
46. Resnick LM. The cellular ionic basis of hypertension and allied clinical conditions. Prog Cardiovasc Dis. 1999;42:1-22.
47. Altura BT, Shirey TL, Young CC, et al. A new method for the rapid determination of ionized Mg2+ in whole blood, serum and plasma. Methods Find Exp Clin Pharmacol. 1992;14:297-304.
48. Altura BT, Shirey TL, Young CC, et al. Characterization of a new ion selective electrode for ionized magnesium in whole blood, plasma, serum, and aqueous samples. Scand J Clin Lab Invest Suppl. 1994;217:21-36.
49. Kawano Y, Matsuoka H, Takishita S, et al. Effects of magnesium supplementation in hypertensive patients: assessment by office, home, and ambulatory blood pressures. Hypertension. 1998;32:260-265.
50. Dyckner T, Wester PO. Effect of magnesium on blood pressure. Br Med J (Clin Res Ed). 1983;286:1847-1849.
51. Cappuccio FP, Markandu ND, Beynon GW, et al. Lack of effect of oral magnesium on high blood pressure: a double blind study. Br Med J (Clin Res Ed). 1985;291:235-238.
52. Resnick LM. Magnesium in the pathophysiology and treatment of hypertension and diabetes mellitus: where are we in 1997? Am J Hypertens. 1997;10:368-370.
53. Resnick LM, Laragh JH. Renin, calcium metabolism and the pathophysiologic basis of antihypertensive therapy. Am J Cardiol. 1985;56:68H-74H.
54. Guerrero-Romero F, Rodriguez-Moran M. Complementary therapies for diabetes: the case for chromium, magnesium, and antioxidants. Arch Med Res. 2005;36:250-257.
55. Rodriguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care. 2003;26:1147-1152.
56. de Valk HW, Verkaaik R, van Rijn HJ, et al. Oral magnesium supplementation in insulin-requiring type 2 diabetic patients. Diabetes Med. 1998;15:503-507.
57. Guerrero-Romero F, Tamez-Perez HE, Gonzalez-Gonzalez G, et al. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab. 2004;30:253-258.